Safety, Tolerability and Pharmacokinetics of Single-ascending and Multiple-ascending Doses of RCS-21 in Healthy Volunteers. a Double Blind, Randomized, Placebo Controlled Phase I Study.

At a glance
Trial Overview
Trial Details
Interventions
Trial Centres
- Investigators
- Centres
Trial History
References

Trial Profile

Safety, Tolerability and Pharmacokinetics of Single-ascending and Multiple-ascending Doses of RCS-21 in Healthy Volunteers. a Double Blind, Randomized, Placebo Controlled Phase I Study.

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 14 Mar 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs RCS-21 (Primary)
Indications COVID 2019 infections
Focus Adverse reactions
Acronyms AMIR-21
Sponsors rnatics

Most Recent Events

11 Mar 2025 Status changed from not yet recruiting to recruiting.
07 Jan 2025 Status changed from planning to not yet recruiting.
23 Dec 2022 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com